Neuraly, Inc.
Author: Michael
Partners can offer clinician-guided peptide ther
The company stops its Phase 2 study of nivisneba
Chi Longevity reflects growing convergence of pr
Allen Law shares his blueprint for closing the h
BioAge will host an R&D Day webcast on 8 May 2026
Clene received final minutes from a Type C meetin
Niagen Bioscience has launched Niagen Plus, a cli
GlycanAge will convene leading academics and clin
Four-day longevity gathering to convene scientis